Cargando…

Usability testing of ANSWER: a web-based methotrexate decision aid for patients with rheumatoid arthritis

BACKGROUND: Decision aids are evidence-based tools designed to inform people of the potential benefit and harm of treatment options, clarify their preferences and provide a shared decision-making structure for discussion at a clinic visit. For patients with rheumatoid arthritis (RA) who are consider...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Linda C, Adam, Paul M, Townsend, Anne F, Lacaille, Diane, Yousefi, Charlene, Stacey, Dawn, Gromala, Diane, Shaw, Chris D, Tugwell, Peter, Backman, Catherine L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4220621/
https://www.ncbi.nlm.nih.gov/pubmed/24289731
http://dx.doi.org/10.1186/1472-6947-13-131
_version_ 1782342760377876480
author Li, Linda C
Adam, Paul M
Townsend, Anne F
Lacaille, Diane
Yousefi, Charlene
Stacey, Dawn
Gromala, Diane
Shaw, Chris D
Tugwell, Peter
Backman, Catherine L
author_facet Li, Linda C
Adam, Paul M
Townsend, Anne F
Lacaille, Diane
Yousefi, Charlene
Stacey, Dawn
Gromala, Diane
Shaw, Chris D
Tugwell, Peter
Backman, Catherine L
author_sort Li, Linda C
collection PubMed
description BACKGROUND: Decision aids are evidence-based tools designed to inform people of the potential benefit and harm of treatment options, clarify their preferences and provide a shared decision-making structure for discussion at a clinic visit. For patients with rheumatoid arthritis (RA) who are considering methotrexate, we have developed a web-based patient decision aid called the ANSWER (Animated, Self-serve, Web-based Research Tool). This study aimed to: 1) assess the usability of the ANSWER prototype; 2) identify strengths and limitations of the ANSWER from the patient’s perspective. METHODS: The ANSWER prototype consisted of: 1) six animated patient stories and narrated information on the evidence of methotrexate for RA; 2) interactive questionnaires to clarify patients’ treatment preferences. Eligible participants for the usability test were patients with RA who had been prescribed methotrexate. They were asked to verbalize their thoughts (i.e., think aloud) while using the ANSWER, and to complete the System Usability Scale (SUS) to assess overall usability (range = 0-100; higher = more user friendly). Participants were audiotaped and observed, and field notes were taken. The testing continued until no new modifiable issues were found. We used descriptive statistics to summarize participant characteristics and the SUS scores. Content analysis was used to identified usability issues and navigation problems. RESULTS: 15 patients participated in the usability testing. The majority were aged 50 or over and were university/college graduates (n = 8, 53.4%). On average they took 56 minutes (SD = 34.8) to complete the tool. The mean SUS score was 81.2 (SD = 13.5). Content analysis of audiotapes and field notes revealed four categories of modifiable usability issues: 1) information delivery (i.e., clarity of the information and presentation style); 2) navigation control (i.e., difficulties in recognizing and using the navigation control buttons); 3) layout (i.e., position of the videos, text, diagrams and navigation buttons); 4) aesthetic (i.e., the colour, look and feel of the online tool). CONCLUSIONS: Although the SUS score indicated high usability before and after major modification, findings from the think-aloud sessions illustrated areas that required further refinement. Our results highlight the importance of formative evaluation in usability testing.
format Online
Article
Text
id pubmed-4220621
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-42206212014-11-06 Usability testing of ANSWER: a web-based methotrexate decision aid for patients with rheumatoid arthritis Li, Linda C Adam, Paul M Townsend, Anne F Lacaille, Diane Yousefi, Charlene Stacey, Dawn Gromala, Diane Shaw, Chris D Tugwell, Peter Backman, Catherine L BMC Med Inform Decis Mak Research Article BACKGROUND: Decision aids are evidence-based tools designed to inform people of the potential benefit and harm of treatment options, clarify their preferences and provide a shared decision-making structure for discussion at a clinic visit. For patients with rheumatoid arthritis (RA) who are considering methotrexate, we have developed a web-based patient decision aid called the ANSWER (Animated, Self-serve, Web-based Research Tool). This study aimed to: 1) assess the usability of the ANSWER prototype; 2) identify strengths and limitations of the ANSWER from the patient’s perspective. METHODS: The ANSWER prototype consisted of: 1) six animated patient stories and narrated information on the evidence of methotrexate for RA; 2) interactive questionnaires to clarify patients’ treatment preferences. Eligible participants for the usability test were patients with RA who had been prescribed methotrexate. They were asked to verbalize their thoughts (i.e., think aloud) while using the ANSWER, and to complete the System Usability Scale (SUS) to assess overall usability (range = 0-100; higher = more user friendly). Participants were audiotaped and observed, and field notes were taken. The testing continued until no new modifiable issues were found. We used descriptive statistics to summarize participant characteristics and the SUS scores. Content analysis was used to identified usability issues and navigation problems. RESULTS: 15 patients participated in the usability testing. The majority were aged 50 or over and were university/college graduates (n = 8, 53.4%). On average they took 56 minutes (SD = 34.8) to complete the tool. The mean SUS score was 81.2 (SD = 13.5). Content analysis of audiotapes and field notes revealed four categories of modifiable usability issues: 1) information delivery (i.e., clarity of the information and presentation style); 2) navigation control (i.e., difficulties in recognizing and using the navigation control buttons); 3) layout (i.e., position of the videos, text, diagrams and navigation buttons); 4) aesthetic (i.e., the colour, look and feel of the online tool). CONCLUSIONS: Although the SUS score indicated high usability before and after major modification, findings from the think-aloud sessions illustrated areas that required further refinement. Our results highlight the importance of formative evaluation in usability testing. BioMed Central 2013-12-01 /pmc/articles/PMC4220621/ /pubmed/24289731 http://dx.doi.org/10.1186/1472-6947-13-131 Text en Copyright © 2013 Li et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Li, Linda C
Adam, Paul M
Townsend, Anne F
Lacaille, Diane
Yousefi, Charlene
Stacey, Dawn
Gromala, Diane
Shaw, Chris D
Tugwell, Peter
Backman, Catherine L
Usability testing of ANSWER: a web-based methotrexate decision aid for patients with rheumatoid arthritis
title Usability testing of ANSWER: a web-based methotrexate decision aid for patients with rheumatoid arthritis
title_full Usability testing of ANSWER: a web-based methotrexate decision aid for patients with rheumatoid arthritis
title_fullStr Usability testing of ANSWER: a web-based methotrexate decision aid for patients with rheumatoid arthritis
title_full_unstemmed Usability testing of ANSWER: a web-based methotrexate decision aid for patients with rheumatoid arthritis
title_short Usability testing of ANSWER: a web-based methotrexate decision aid for patients with rheumatoid arthritis
title_sort usability testing of answer: a web-based methotrexate decision aid for patients with rheumatoid arthritis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4220621/
https://www.ncbi.nlm.nih.gov/pubmed/24289731
http://dx.doi.org/10.1186/1472-6947-13-131
work_keys_str_mv AT lilindac usabilitytestingofanswerawebbasedmethotrexatedecisionaidforpatientswithrheumatoidarthritis
AT adampaulm usabilitytestingofanswerawebbasedmethotrexatedecisionaidforpatientswithrheumatoidarthritis
AT townsendannef usabilitytestingofanswerawebbasedmethotrexatedecisionaidforpatientswithrheumatoidarthritis
AT lacaillediane usabilitytestingofanswerawebbasedmethotrexatedecisionaidforpatientswithrheumatoidarthritis
AT youseficharlene usabilitytestingofanswerawebbasedmethotrexatedecisionaidforpatientswithrheumatoidarthritis
AT staceydawn usabilitytestingofanswerawebbasedmethotrexatedecisionaidforpatientswithrheumatoidarthritis
AT gromaladiane usabilitytestingofanswerawebbasedmethotrexatedecisionaidforpatientswithrheumatoidarthritis
AT shawchrisd usabilitytestingofanswerawebbasedmethotrexatedecisionaidforpatientswithrheumatoidarthritis
AT tugwellpeter usabilitytestingofanswerawebbasedmethotrexatedecisionaidforpatientswithrheumatoidarthritis
AT backmancatherinel usabilitytestingofanswerawebbasedmethotrexatedecisionaidforpatientswithrheumatoidarthritis